Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Theralink Technologies (THER)
OTHER OTC:THER
Holding THER?
Track your performance easily
THER Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range― - ―
Previous Close$0.02
Volume2.36M
Average Volume (3M)N/A
Market Cap
$615.15K
Enterprise Value$1.76M
Total Cash (Recent Filing)$24.27K
Total Debt (Recent Filing)$1.17M
Price to Earnings (P/E)―
Beta-122.86
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding6,151,499,919
10 Day Avg. Volume26,348
30 Day Avg. VolumeN/A
Standard Deviation6.66
R-Squared0.03
Alpha0.76
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.01
Price to Sales (P/S)0.97
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.45
Enterprise Value/Gross Profit3.67
Enterprise Value/Ebitda-0.06
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
THER FAQ
What was Theralink Technologies’s price range in the past 12 months?
Currently, no data Available
What is Theralink Technologies’s market cap?
Currently, no data Available
When is Theralink Technologies’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Theralink Technologies’s earnings last quarter?
Currently, no data Available
Is Theralink Technologies overvalued?
According to Wall Street analysts Theralink Technologies’s price is currently Overvalued.
Does Theralink Technologies pay dividends?
Theralink Technologies does not currently pay dividends.
What is Theralink Technologies’s EPS estimate?
Theralink Technologies’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Theralink Technologies have?
Theralink Technologies has 6,151,500,000 shares outstanding.
What happened to Theralink Technologies’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Theralink Technologies?
Currently, no hedge funds are holding shares in THER
---
Company Description
Theralink Technologies
OncBioMune Pharmaceuticals, Inc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its products include vaccines, PA-OBC, and PGT-RC. The company was founded on March 18, 2005 and is headquartered in Baton Rouge, LA.
---
---